Atossa Therapeutics (ATOS) Asset Utilization Ratio (2012 - 2016)
Atossa Therapeutics (ATOS) posted quarterly Asset Utilization Ratio of 0.0 for Q3 2016, up 95.96% year-over-year from 0.0 in Q4 2015, and down 12.32% quarter-over-quarter from 0.0 in Q2 2016.
Atossa Therapeutics (ATOS) Asset Utilization Ratio (2012 - 2016) Analysis & Trends
Atossa Therapeutics (ATOS) has reported Asset Utilization Ratio for 5 consecutive years, with 0.0 the latest figure, recorded in Q3 2016.
- In Q3 2016, Asset Utilization Ratio rose 95.96% year-over-year to 0.0; the TTM figure through Sep 2016 stood at 0.0 (up 95.96% YoY), while the FY2015 annual figure was 0.0, down 94.22% from the prior year.
- Asset Utilization Ratio retreated to 0.0 in Q3 2016 per ATOS's latest filing, from 0.0 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.04 in Q2 2013 and bottomed at 0.02 in Q3 2014.
- Historically, Asset Utilization Ratio has averaged 0.0 across 5 years, with a median of 0.0 in 2015.
- On a YoY basis, Asset Utilization Ratio climbed as much as 123.02% in 2014 and fell as far as 168.53% in 2014.
- Atossa Therapeutics' Asset Utilization Ratio stood at 0.03 in 2012, then plunged by 136.58% to 0.01 in 2013, then surged by 123.02% to 0.0 in 2014, then sank by 93.28% to 0.0 in 2015, then surged by 94.51% to 0.0 in 2016.
- Business Quant data shows ATOS's Asset Utilization Ratio at 0.0 in Q3 2016, 0.0 in Q2 2016, and 0.0 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 0.13 |
| 10 | Atossa Therapeutics | 22.79 Mn | 22.79 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 0.00 |
| Jun 30, 2016 | 0.00 |
| Mar 31, 2016 | 0.00 |
| Dec 31, 2015 | 0.00 |
| Sep 30, 2015 | 0.00 |
| Jun 30, 2015 | 0.00 |
| Mar 31, 2015 | 0.00 |
| Dec 31, 2014 | 0.00 |
| Sep 30, 2014 | -0.02 |
| Jun 30, 2014 | -0.01 |
| Mar 31, 2014 | -0.01 |
| Dec 31, 2013 | -0.01 |
| Sep 30, 2013 | 0.03 |
| Jun 30, 2013 | 0.04 |
| Mar 31, 2013 | 0.03 |
| Dec 31, 2012 | 0.03 |